Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state.
paper
Cited
Public
Unavailable
- Authors
- Lapasset, Laure; Milhavet, Ollivier; Prieur, Alexandre; Besnard, Emilie; Babled, Amelie; AΓ―t-Hamou, Nafissa; Leschik, Julia; Pellestor, Franck; Ramirez, Jean-Marie; De Vos, John; Lehmann, Sylvain; Lemaitre, Jean-Marc
- Year
- 2011
- Journal
- Genes & development
- PMID
- 22056670
- DOI
- 10.1101/gad.173922.111
- PMCID
- PMC3219229
Direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) provides a unique opportunity to derive patient-specific stem cells with potential applications in tissue replacement therapies and without the ethical concerns of human embryonic stem cells (hESCs). However, cellular senescence, which contributes to aging and restricted longevity, has been described as a barrier to the derivation of iPSCs. Here we demonstrate, using an optimized protocol, that cellular senescence is not a limit to reprogramming and that age-related cellular physiology is reversible. Thus, we show that our iPSCs generated from senescent and centenarian cells have reset telomere size, gene expression profiles, oxidative stress, and mitochondrial metabolism, and are indistinguishable from hESCs. Finally, we show that senescent and centenarian-derived pluripotent stem cells are able to redifferentiate into fully rejuvenated cells. These results provide new insights into iPSC technology and pave the way for regenerative medicine for aged patients.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Age-independent and targetable transcription factor networks regulating CD8<sup>+</sup> T cell senescence in aging humans. | Turano PS et al. | β | 2026 | β |
| Directed differentiation of human mesenchymal stromal cells into functional endothelial cells having IKAROS-mediated immune tolerance properties. | Han JK et al. | β | 2026 | β |
| From Dish to Trial: Building Translational Models of ALS. | Salamotas I et al. | β | 2026 | β |
| Introducing Cellular Senescence in Human Induced Pluripotent Stem Cells and Differentiated Neural Lineage for Modeling of Age-Associated Diseases. | Neherin K et al. | β | 2026 | β |
| Of Barriers and Loops-How Evolution Limits Most Cancer Risks to Older Ages. | De Dominici M et al. | β | 2026 | β |
| A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications. | Matiukhova M et al. | β | 2025 | β |
| Advances in stem cell-derived exosome therapy for radiation-induced skin injury. | Kuo PJ et al. | β | 2025 | β |
| Altered Heme and Redox Homeostasis Underpin Late-onset Alzheimer's Disease. | Soladogun AS et al. | β | 2025 | β |
| Anti-senescence therapies: a new concept to address cardiovascular disease. | StojanoviΔ SD et al. | β | 2025 | β |
| Cell reprogramming: methods, mechanisms and applications. | Zhu F et al. | β | 2025 | β |
| Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan. | Schoenfeldt L et al. | β | 2025 | β |
| Comparative analysis of mouse strains for in vivo induction of reprogramming factors. | PicΓ³ S et al. | β | 2025 | β |
| Conserved biological processes in partial cellular reprogramming: Relevance to aging and rejuvenation. | Avelar RA et al. | β | 2025 | β |
| Control of Mycobacterium tuberculosis infection in the elderly: Is there a role for epigenetic reprogramming reversal? | Romero-RodrΓguez DP et al. | β | 2025 | β |
| Elevated p16Ink4a Expression Enhances Tau Phosphorylation in Neurons Differentiated From Human-Induced Pluripotent Stem Cells. | Holloway K et al. | β | 2025 | β |
| Epigenetic age acceleration and psychosocial stressors in early childhood. | Mulligan CJ | β | 2025 | β |
| Exosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cells. | Bi Y et al. | β | 2025 | β |
| Functional diversity of senescent cells in driving ageing phenotypes and facilitating tissue regeneration. | Nakano Y et al. | β | 2025 | β |
| Identifying Age-Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age. | Zhang C et al. | β | 2025 | β |
| Inhibition of mesenchymal drift as a strategy for rejuvenation. | de Lima Camillo LP | β | 2025 | β |
| Interrogating the regulatory epigenome of cellular senescence. | Thanos DF et al. | β | 2025 | β |
| Investigating the ageing-Parkinson's disease nexus: standardisation of in vitro models and techniques by the PD-AGE network. | Bury AG et al. | β | 2025 | β |
| Is the liver resilient to the process of ageing? | Chatterjee N et al. | β | 2025 | β |
| MskAge-An Epigenetic Biomarker of Musculoskeletal Age Derived From a Genetic Algorithm Islands Model. | Green DC et al. | β | 2025 | β |
| Preexisting Genetic Background Primes the Responses of Human Neurons to Amyloid Ξ². | Soladogun AS et al. | β | 2025 | β |
| Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming. | Lu JY et al. | β | 2025 | β |
| Probing DNA damage in Rett syndrome neurons uncovers a role for MECP2 regulation of PARP1. | Morales A et al. | β | 2025 | β |
| Rejuvenation of mesenchymal stem cells by human peripheral blood lymphocytes. | Luo Y et al. | β | 2025 | β |
| Reprogramming to restore youthful epigenetics of senescent nucleus pulposus cells for mitigating intervertebral disc degeneration and alleviating low back pain. | Ma W et al. | β | 2025 | β |
| Restoration of angiogenic capacity in senescent endothelial cells by a pharmacological reprogramming approach. | Kalies K et al. | β | 2025 | β |
| Revitalizing the Epigenome of Adult Jaw Periosteal Cells: Enhancing Diversity in iPSC-Derived Mesenchymal Stem Cells (iMSCs). | Umrath F et al. | β | 2025 | β |
| Role of Cellular Senescence in Parkinson's Disease: Potential for Disease-Modification Through Senotherapy. | Rademacher DJ et al. | β | 2025 | β |
| Somatic cell reprogramming from different origins and donors into iPSC, with four factors OSKM using viral Sendai vectors. | Desprat R et al. | β | 2025 | β |
| Stem cell-based therapeutic strategies for liver aging. | Niu H et al. | β | 2025 | β |
| Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review. | Narasimha RB et al. | β | 2025 | β |
| Targeted partial reprogramming as a novel therapeutic strategy for age-related decline. | Rose M et al. | β | 2025 | β |
| Telomeres as hallmarks of iPSC aging: A review on telomere dynamics during stemness and cellular reprogramming. | Tavares-Marcos C et al. | β | 2025 | β |
| The Potential of Polyphenols in Modulating the Cellular Senescence Process: Implications and Mechanism of Action. | Della Vedova L et al. | β | 2025 | β |
| Tracing mitochondrial marks of neuronal aging in iPSCs-derived neurons and directly converted neurons. | Varghese N et al. | β | 2025 | β |
| A cellular identity crisis? Plasticity changes during aging and rejuvenation. | Gorelov R et al. | β | 2024 | β |
| Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming. | Luo C et al. | β | 2024 | β |
| Application of mesenchymal stem/stromal cells in periodontal regeneration: Opportunities and challenges. | Gao P et al. | β | 2024 | β |
| A Youthful Touch: Reversal of Aging Hallmarks by Cell Reprogramming. | Miliotou E et al. | β | 2024 | β |
| Cellular reprogramming as a tool to model human aging in a dish. | Pitrez PR et al. | β | 2024 | β |
| Cellular senescence in cancer: molecular mechanisms and therapeutic targets. | Jin P et al. | β | 2024 | β |
| Cellular senescence: Neither irreversible nor reversible. | Reimann M et al. | β | 2024 | β |
| Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects. | Alidadi M et al. | β | 2024 | β |
| Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics. | Fraile-Martinez O et al. | β | 2024 | β |
| Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls. | Tsitkov S et al. | β | 2024 | β |
| Emerging Roles of Vitamin B<sub>12</sub> in Aging and Inflammation. | Simonenko SY et al. | β | 2024 | β |
| Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma. | HernΓ‘ndez-MagaΓ±a A et al. | β | 2024 | β |
| Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration. | Saurat N et al. | β | 2024 | β |
| Human iPSCs from Aged Donors Retain Their Mitochondrial Aging Signature. | Lejri I et al. | β | 2024 | β |
| IFNΞ³ protects motor neurons from oxidative stress via enhanced global protein synthesis in FUS-associated amyotrophic lateral sclerosis. | Assoni AF et al. | β | 2024 | β |
| Immunosenescence and Inflamm-Aging: Clinical Interventions and the Potential for Reversal of Aging. | Kumar SJ et al. | β | 2024 | β |
| Lessons from inducible pluripotent stem cell models on neuronal senescence in aging and neurodegeneration. | de Luzy IR et al. | β | 2024 | β |
| Leveraging Cell Migration Dynamics to Discriminate Between Senescent and Presenescent Human Mesenchymal Stem Cells. | Amiri F et al. | β | 2024 | β |
| Linking Aging to Cancer: The Role of Chromatin Biology. | Corveleyn L et al. | β | 2024 | β |
| Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin. | Lemaitre JM | β | 2024 | β |
| Mapping the future of oxidative RNA damage in neurodegeneration: Rethinking the status quo with new tools. | Wheeler HB et al. | β | 2024 | β |
| Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming. | Cipriano A et al. | β | 2024 | β |
| Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming. | Sun Z et al. | β | 2024 | β |
| New developments in pre-clinical models of ALS to guide translation. | De Cock L et al. | β | 2024 | β |
| Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology. | Paine PT et al. | β | 2024 | β |
| Partial Reprogramming Exerts a Rejuvenating Effect on Human Mesenchymal Stem Cells That Underwent Replicative Senescence in Culture. | Ivanova J et al. | β | 2024 | β |
| [Postnatal epigenome-mediated aging control and global trends]. | Hayano M | β | 2024 | β |
| Potential Clinical Implications of Senotherapies for Cardiovascular Disease. | Suda M et al. | β | 2024 | β |
| Preservation of an Aging-Associated Mitochondrial Signature in Advanced Human Neuronal Models | Varghese N et al. | β | 2024 | β |
| Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS. | Tsekrekou M et al. | β | 2024 | β |
| Research progress of autoimmune diseases based on induced pluripotent stem cells. | Ren R et al. | β | 2024 | β |
| Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche. | Xu L et al. | β | 2024 | β |
| Strategies for modeling aging and age-related diseases. | Jothi D et al. | β | 2024 | β |
| Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes. | Harley J et al. | β | 2024 | β |
| The role of glial cells in amyotrophic lateral sclerosis. | Pandya VA et al. | β | 2024 | β |
| Towards a Novel Frontier in the Use of Epigenetic Clocks in Epidemiology. | MartΓnez-MagaΓ±a JJ et al. | β | 2024 | β |
| Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations. | Tripathi U et al. | β | 2024 | β |
| Young Plasma Rejuvenates Blood DNA Methylation Profile, Extends Mean Lifespan, and Improves Physical Appearance in Old Rats. | Chiavellini P et al. | β | 2024 | β |
| 3D ECM-Based Scaffolds Boost Young Cell Secretome-Derived EV Rejuvenating Effects in Senescent Cells. | Arcuri S et al. | β | 2023 | β |
| Ageing in the brain: mechanisms and rejuvenating strategies. | Gaspar-Silva F et al. | β | 2023 | β |
| Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. | Mead RJ et al. | β | 2023 | β |
| Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies. | McCaughey-Chapman A et al. | β | 2023 | β |
| Cell Reprogramming Strategies for Treating Osteoarthritis and Intervertebral Disc Degeneration. | Jiang Z et al. | β | 2023 | β |
| Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. | Ji S et al. | β | 2023 | β |
| Cellular senescence and neurodegeneration. | Holloway K et al. | β | 2023 | β |
| Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges. | Li D et al. | β | 2023 | β |
| Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives. | Wang J et al. | β | 2023 | β |
| Chemokine/ITGA4 Interaction Directs iPSC-Derived Myogenic Progenitor Migration to Injury Sites in Aging Muscle for Regeneration. | Ashraf M et al. | β | 2023 | β |
| Chromatin: the old and young of it. | Emerson FJ et al. | β | 2023 | β |
| Clinical Impact and Mechanisms of Nonatherosclerotic Vascular Aging: The New Kid to Be Blocked. | Jouabadi SM et al. | β | 2023 | β |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Eremeev A et al. | β | 2023 | β |
| Context-dependent roles of cellular senescence in normal, aged, and disease states. | Moiseeva V et al. | β | 2023 | β |
| Development of an accelerated cellular model for early changes in Alzheimer's disease. | Xue H et al. | β | 2023 | β |
| Embryonic stem cell-derived extracellular vesicles rejuvenate senescent cells and antagonize aging in mice. | Yu L et al. | β | 2023 | β |
| Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. | Khalil R et al. | β | 2023 | β |
| Endothelial cell direct reprogramming: Past, present, and future. | Cho S et al. | β | 2023 | β |
| Engineering of extracellular matrix from human iPSC-mesenchymal progenitors to enhance osteogenic capacity of human bone marrow stromal cells independent of their age. | Hanetseder D et al. | β | 2023 | β |
| Epigenetic rejuvenation by partial reprogramming. | Puri D et al. | β | 2023 | β |
| Extended lifespan and improved genome stability in HepaRG-derived cell lines through reprogramming by high-density stress. | Brun C et al. | β | 2023 | β |
| Fountain of youth-Targeting autophagy in aging. | Danics L et al. | β | 2023 | β |
| Impact of aging on tendon homeostasis, tendinopathy development, and impaired healing. | Korcari A et al. | β | 2023 | β |
| Initiation phase cellular reprogramming ameliorates DNA damage in the ERCC1 mouse model of premature aging. | Paine PT et al. | β | 2023 | β |
| In vivo reprogramming leads to premature death linked to hepatic and intestinal failure. | Parras A et al. | β | 2023 | β |
| Metabolic and cell cycle shift induced by the deletion of Dnm1l attenuates the dissolution of pluripotency in mouse embryonic stem cells. | Seo BJ et al. | β | 2023 | β |
| Neural cell state shifts and fate loss in ageing and age-related diseases. | Traxler L et al. | β | 2023 | β |
| Reprogramming of adult human dermal fibroblasts to induced dorsal forebrain precursor cells maintains aging signatures. | McCaughey-Chapman A et al. | β | 2023 | β |
| Reversing and modulating cellular senescence in beta cells, a new field of opportunities to treat diabetes. | Rubin de Celis MF et al. | β | 2023 | β |
| Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. | Suda M et al. | β | 2023 | β |
| Spinal Cord Organoids to Study Motor Neuron Development and Disease. | Buchner F et al. | β | 2023 | β |
| Synergistic Effect of miR-200 and Young Extracellular Matrix-based Bio-scaffolds to Reduce Signs of Aging in Senescent Fibroblasts. | Pennarossa G et al. | β | 2023 | β |
| The Information Theory of Aging. | Lu YR et al. | β | 2023 | β |
| Transcriptomic reprogramming for neuronal age reversal. | Plesa AM et al. | β | 2023 | β |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Guerreiro S et al. | β | 2023 | β |
| Turning Back the Clock: A Retrospective Single-Blind Study on Brain Age Change in Response to Nutraceuticals Supplementation vs. Lifestyle Modifications. | Fingelkurts AA et al. | β | 2023 | β |
| 3-deazaadenosine (3DA) alleviates senescence to promote cellular fitness and cell therapy efficiency in mice. | Guerrero A et al. | β | 2022 | β |
| Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors. | Carvalho AB et al. | β | 2022 | β |
| Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells. | Morsli S et al. | β | 2022 | β |
| Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease. | Drouin-Ouellet J et al. | β | 2022 | β |
| Age reprogramming: cell rejuvenation by partial reprogramming. | Singh PB et al. | β | 2022 | β |
| Aging is a Side Effect of the Ontogenesis Program of Multicellular Organisms. | Salnikov L | β | 2022 | β |
| Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS. | GΓΌnther R et al. | β | 2022 | β |
| A new insight into cell biological and biochemical changes through aging. | Sahabi S et al. | β | 2022 | β |
| A single short reprogramming early in life initiates and propagates an epigenetically related mechanism improving fitness and promoting an increased healthy lifespan. | Alle Q et al. | β | 2022 | β |
| Cellular senescence: a key therapeutic target in aging and diseases. | Zhang L et al. | β | 2022 | β |
| Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs. | Kudlova N et al. | β | 2022 | β |
| Chemically induced senescence in human stem cell-derived neurons promotes phenotypic presentation of neurodegeneration. | Fathi A et al. | β | 2022 | β |
| Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion. | BΓΆhnke L et al. | β | 2022 | β |
| Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. | Tcw J et al. | β | 2022 | β |
| Comparative transcriptomics reveals circadian and pluripotency networks as two pillars of longevity regulation. | Lu JY et al. | β | 2022 | β |
| Current Development, Obstacle and Futural Direction of Induced Pluripotent Stem Cell and Mesenchymal Stem Cell Treatment in Degenerative Retinal Disease. | Chiang MC et al. | β | 2022 | β |
| Direct Cell Conversion of Somatic Cells into Dopamine Neurons: Achievements and Perspectives. | Aversano S et al. | β | 2022 | β |
| Direct Conversion of Cell Fate and Induced Endothelial Cells. | Han JK et al. | β | 2022 | β |
| Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming. | Legault EM et al. | β | 2022 | β |
| Diverse partial reprogramming strategies restore youthful gene expression and transiently suppress cell identity. | Roux AE et al. | β | 2022 | β |
| Effects of lifespan-extending interventions on cognitive healthspan. | Culig L et al. | β | 2022 | β |
| Epigenetic regulation of aging: implications for interventions of aging and diseases. | Wang K et al. | β | 2022 | β |
| Epigenetic Regulation of Cellular Senescence. | Crouch J et al. | β | 2022 | β |
| Establishment of fishing cat cell biobanking for sustainable conservation. | Sukparangsi W et al. | β | 2022 | β |
| How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span. | Galow AM et al. | β | 2022 | β |
| Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine. | Poetsch MS et al. | β | 2022 | β |
| Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures. | Aversano S et al. | β | 2022 | β |
| Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis. | AmorΓ³s MA et al. | β | 2022 | β |
| Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. | Gill D et al. | β | 2022 | β |
| Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming. | Chondronasiou D et al. | β | 2022 | β |
| Oxidative stress, aging, antioxidant supplementation and their impact on human health: An overview. | Martemucci G et al. | β | 2022 | β |
| Personalized Scaffolds for Diabetic Foot Ulcer Healing Using Extracellular Matrix from Induced Pluripotent Stem-Reprogrammed Patient Cells. | Santarella F et al. | β | 2022 | β |
| Pre-Conditioning with IFN-Ξ³ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome. | Wang S et al. | β | 2022 | β |
| Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons. | Castillo Bautista CM et al. | β | 2022 | β |
| Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. | Capano LS et al. | β | 2022 | β |
| Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors. | Cai Y et al. | β | 2022 | β |
| Repair, regeneration and rejuvenation require un-entangling pluripotency from senescence. | Tabibzadeh S | β | 2022 | β |
| RNA-Based Strategies for Cell Reprogramming toward Pluripotency. | Bailly A et al. | β | 2022 | β |
| Single short reprogramming early in life increases healthspan. | Milhavet O et al. | β | 2022 | β |
| Structural Variation at a Disease Mutation Hotspot: Strategies to Investigate Gene Regulation and the 3D Genome. | Boyling A et al. | β | 2022 | β |
| The intricate nature of senescence in development and cell plasticity. | Gal H et al. | β | 2022 | β |
| Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics. | Leng K et al. | β | 2022 | β |
| Will Life Extension Affect Our Social Judgments? Evidence That the Possibility of Indefinite Life Extension Increases Harshness Toward Social Transgressors. | Helm PJ et al. | β | 2022 | β |
| Adipose-Derived Mesenchymal Stromal Cells in Regenerative Medicine: State of Play, Current Clinical Trials, and Future Prospects. | Laloze J et al. | β | 2021 | β |
| Aging and rejuvenation - a modular epigenome model. | Chiavellini P et al. | β | 2021 | β |
| Bcl-xL as a Modulator of Senescence and Aging. | Mas-Bargues C et al. | β | 2021 | β |
| Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis. | De Blander H et al. | β | 2021 | β |
| Cellular reprogramming and epigenetic rejuvenation. | Simpson DJ et al. | β | 2021 | β |
| Creating stem cell-derived neuromuscular junctions in vitro. | Luttrell SM et al. | β | 2021 | β |
| Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by MicroRNAs. | Cates K et al. | β | 2021 | β |
| Differentiation reveals latent features of aging and an energy barrier in murine myogenesis. | Kimmel JC et al. | β | 2021 | β |
| Direct Conversion of Human Fibroblasts to Induced Neurons. | Zhou-Yang L et al. | β | 2021 | β |
| Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease. | Gatto N et al. | β | 2021 | β |
| Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration. | Gudenschwager C et al. | β | 2021 | β |
| Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia. | Ding B et al. | β | 2021 | β |
| Early functional changes associated with alpha-synuclein proteinopathy in engineered human neural networks. | Valderhaug VD et al. | β | 2021 | β |
| Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration. | Arnold F et al. | β | 2021 | β |
| GATA6 regulates aging of human mesenchymal stem/stromal cells. | Jiao H et al. | β | 2021 | β |
| Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery. | Qian L et al. | β | 2021 | β |
| Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging. | Chao CC et al. | β | 2021 | β |
| iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter? | Scesa G et al. | β | 2021 | β |
| Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. | Kumari R et al. | β | 2021 | β |
| Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging femalesβ . | Zhang C et al. | β | 2021 | β |
| Myc determines the functional age state of oligodendrocyte progenitor cells. | Neumann B et al. | β | 2021 | β |
| No Time to Age: Uncoupling Aging from Chronological Time. | Larocca D et al. | β | 2021 | β |
| Novel epigenetic clock for fetal brain development predicts prenatal age for cellular stem cell models and derived neurons. | Steg LC et al. | β | 2021 | β |
| One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2. | Chanoumidou K et al. | β | 2021 | β |
| Phenotyping Neurodegeneration in Human iPSCs. | Li J et al. | β | 2021 | β |
| Reprogrammed Synovial Fluid-Derived Mesenchymal Stem/Stromal Cells Acquire Enhanced Therapeutic Potential for Articular Cartilage Repair. | Walczak BE et al. | β | 2021 | β |
| Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues. | Alle Q et al. | β | 2021 | β |
| Senescent Cells in Cancer: Wanted or Unwanted Citizens. | Niklander SE et al. | β | 2021 | β |
| 4D Genome Rewiring during Oncogene-Induced and Replicative Senescence. | Sati S et al. | β | 2020 | β |
| Asymmetric cell division and replicative aging: a new perspective from the spindle poles. | Manzano-LΓ³pez J et al. | β | 2020 | β |
| Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells. | Tanaka N et al. | β | 2020 | β |
| Differential Influence of Sample Sex and Neuronal Maturation on mRNA and Protein Transport in Induced Human Neurons. | Ding B et al. | β | 2020 | β |
| Direct conversion of human fibroblasts into therapeutically active vascular wall-typical mesenchymal stem cells. | Steens J et al. | β | 2020 | β |
| DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan. | Bergsma T et al. | β | 2020 | β |
| Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease. | Riemens RJM et al. | β | 2020 | β |
| Human Organoids for the Study of Retinal Development and Disease. | Bell CM et al. | β | 2020 | β |
| iPSC-Derived MSCs Versus Originating Jaw Periosteal Cells: Comparison of Resulting Phenotype and Stem Cell Potential. | Umrath F et al. | β | 2020 | β |
| Mental health dished up-the use of iPSC models in neuropsychiatric research. | McNeill RV et al. | β | 2020 | β |
| Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer's disease. | Klimmt J et al. | β | 2020 | β |
| Novel insights into inner ear development and regeneration for targeted hearing loss therapies. | Roccio M et al. | β | 2020 | β |
| Optimized Approaches for the Induction of Putative Canine Induced Pluripotent Stem Cells from Old Fibroblasts Using Synthetic RNAs. | Kim M et al. | β | 2020 | β |
| Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery. | Marotta N et al. | β | 2020 | β |
| Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming. | Khoo TS et al. | β | 2020 | β |
| Scaffolds Functionalized with Matrix from Induced Pluripotent Stem Cell Fibroblasts for Diabetic Wound Healing. | Santarella F et al. | β | 2020 | β |
| Senescence-Associated Metabolomic Phenotype in Primary and iPSC-Derived Mesenchymal Stromal Cells. | Fernandez-Rebollo E et al. | β | 2020 | β |
| Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis. | StojanoviΔ SD et al. | β | 2020 | β |
| The ageing epigenome and itsΒ rejuvenation. | Zhang W et al. | β | 2020 | β |
| The iNs and Outs of Direct Reprogramming to Induced Neurons. | Carter JL et al. | β | 2020 | β |
| The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons. | Sharlow ER et al. | β | 2020 | β |
| Wandering along the epigenetic timeline. | Topart C et al. | β | 2020 | β |
| Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases. | Sato M et al. | β | 2019 | β |
| Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts. | Vosough M et al. | β | 2019 | β |
| Approaches towards Longevity: Reprogramming, Senolysis, and Improved Mitotic Competence as Anti-Aging Therapies. | Melo Pereira S et al. | β | 2019 | β |
| Cellular Senescence: Aging, Cancer, and Injury. | Calcinotto A et al. | β | 2019 | β |
| Compromised Chondrocyte Differentiation Capacity in TERC Knockout Mouse Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer. | Chang WF et al. | β | 2019 | β |
| Deconstructing age reprogramming. | Singh PB et al. | β | 2019 | β |
| Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes. | Kashpur O et al. | β | 2019 | β |
| Emerging opportunities for induced pluripotent stem cells in orthopaedics. | Li WJ et al. | β | 2019 | β |
| Epigenetic changes during aging and their reprogramming potential. | Kane AE et al. | β | 2019 | β |
| Epigenetic Clock: Just a Convenient Marker or an Active Driver of Aging? | Ashapkin VV et al. | β | 2019 | β |
| Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing. | Mahmoudi S et al. | β | 2019 | β |
| Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases. | Tcw J | β | 2019 | β |
| Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. | Spitzhorn LS et al. | β | 2019 | β |
| <i>In silico</i> clinical trials for anti-aging therapies. | Menendez JA et al. | β | 2019 | β |
| Impelling force and current challenges by chemicals in somatic cell reprogramming and expansion beyond hepatocytes. | Ge JY et al. | β | 2019 | β |
| Induced pluripotent stem cells, a giant leap for mankind therapeutic applications. | BraganΓ§a J et al. | β | 2019 | β |
| LncRNAs regulating stemness in aging. | Sousa-Franco A et al. | β | 2019 | β |
| Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles. | Marolt Presen D et al. | β | 2019 | β |
| Methods for evaluating variability in human health dose-response characterization. | Axelrad DA et al. | β | 2019 | β |
| Multiplication of the SNCA locus exacerbates neuronal nuclear aging. | Tagliafierro L et al. | β | 2019 | β |
| Next-generation disease modeling with direct conversion: a new path to old neurons. | Traxler L et al. | β | 2019 | β |
| Putting the brakes on the cell cycle: mechanisms of cellular growth arrest. | Pack LR et al. | β | 2019 | β |
| Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere length. | Gatinois V et al. | β | 2019 | β |
| Reversibility of irreversible aging. | Galkin F et al. | β | 2019 | β |
| Short Review: Investigating ARSACS: models for understanding cerebellar degeneration. | Artero Castro A et al. | β | 2019 | β |
| Stem cells: past, present, and future. | Zakrzewski W et al. | β | 2019 | β |
| Targeting senescent cells in translational medicine. | Paez-Ribes M et al. | β | 2019 | β |
| Turning back time with emerging rejuvenation strategies. | Mahmoudi S et al. | β | 2019 | β |
| WDR5, BRCA1, and BARD1 Co-regulate the DNA Damage Response andΒ Modulate the Mesenchymal-to-Epithelial Transition during Early Reprogramming. | PeΓ±alosa-Ruiz G et al. | β | 2019 | β |
| Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality. | StrΓ€ssler ET et al. | β | 2018 | β |
| Age-Related Epigenetic Derangement upon Reprogramming and Differentiation of Cells from the Elderly. | Ravaioli F et al. | β | 2018 | β |
| Age reprogramming and epigenetic rejuvenation. | Singh PB et al. | β | 2018 | β |
| Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. | Mertens J et al. | β | 2018 | β |
| Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies. | Daniszewski M et al. | β | 2018 | β |
| Cellular reprogramming: A new way to understand aging mechanisms. | Yener Ilce B et al. | β | 2018 | β |
| Cellular senescence induces replication stress with almost no affect on DNA replication timing. | Rivera-Mulia JC et al. | β | 2018 | β |
| Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development. | Fermini B et al. | β | 2018 | β |
| Clusterin Is Required for Ξ²-Amyloid Toxicity in Human iPSC-Derived Neurons. | Robbins JP et al. | β | 2018 | β |
| Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics? | Assou S et al. | β | 2018 | β |
| Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells. | Hsu YC et al. | β | 2018 | β |
| Editorial: Mechanisms and Implications of the Aging of Cardiovascular Regenerative Cells. | Beltrami AP et al. | β | 2018 | β |
| Elixir of Life: Thwarting Aging With Regenerative Reprogramming. | Beyret E et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| High-efficiency RNA-based reprogramming of human primary fibroblasts. | Kogut I et al. | β | 2018 | β |
| Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances. | McCaughey-Chapman A et al. | β | 2018 | β |
| Implications of Cellular Aging in Cardiac Reprogramming. | Passaro F et al. | β | 2018 | β |
| Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1. | Chien Y et al. | β | 2018 | β |
| Inhibition of p16<sup>INK4A</sup> to Rejuvenate Aging Human Cardiac Progenitor Cells via the Upregulation of Anti-oxidant and NFΞΊB Signal Pathways. | Khatiwala RV et al. | β | 2018 | β |
| Interrupted reprogramming into induced pluripotent stem cells does not rejuvenate human mesenchymal stromal cells. | GΓΆbel C et al. | β | 2018 | β |
| In vivo somatic cell reprogramming for tissue regeneration: the emerging role of the local microenvironment. | Pesaresi M et al. | β | 2018 | β |
| In Vivo Transient and Partial Cell Reprogramming to Pluripotency as a Therapeutic Tool for Neurodegenerative Diseases. | Tamanini S et al. | β | 2018 | β |
| Mechanistic Insights Into MicroRNA-Induced Neuronal Reprogramming of Human Adult Fibroblasts. | Lu YL et al. | β | 2018 | β |
| Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering. | Fitzsimmons REB et al. | β | 2018 | β |
| Mice deficient in the Shmt2 gene have mitochondrial respiration defects and are embryonic lethal. | Tani H et al. | β | 2018 | β |
| Microglia in Alzheimer's Disease: A Role for Ion Channels. | Thei L et al. | β | 2018 | β |
| Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases. | Giorgi C et al. | β | 2018 | β |
| Mitochondrial Aging Defects Emerge in Directly Reprogrammed Human Neurons due to Their Metabolic Profile. | Kim Y et al. | β | 2018 | β |
| Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo. | Doeser MC et al. | β | 2018 | β |
| Regulation of Age-related Decline by Transcription Factors and Their Crosstalk with the Epigenome. | Zhou X et al. | β | 2018 | β |
| Rejuvenation by cell reprogramming: a new horizon in gerontology. | Goya RG et al. | β | 2018 | β |
| Senescence and aging: Causes, consequences, and therapeutic avenues. | McHugh D et al. | β | 2018 | β |
| Silencing of the lncRNA Zeb2-NAT facilitates reprogramming of aged fibroblasts and safeguards stem cell pluripotency. | Bernardes de Jesus B et al. | β | 2018 | β |
| Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts. | Shrigley S et al. | β | 2018 | β |
| TGF-Ξ² signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging. | Lyu G et al. | β | 2018 | β |
| The effect of age on stem cell function and utility for therapy. | Narbonne P | β | 2018 | β |
| The potential of human induced pluripotent stem cells for modelling diabetic wound healing <i>in vitro</i>. | Martin PE et al. | β | 2018 | β |
| The senescent cell epigenome. | Yang N et al. | β | 2018 | β |
| Unveiling epigenetic regulation in cancer, aging, and rejuvenation with inΒ vivo reprogramming technology. | Sogabe Y et al. | β | 2018 | β |
| Aged induced pluripotent stem cell (iPSCs) as a new cellular model for studying premature aging. | Petrini S et al. | β | 2017 | β |
| Aging as an Epigenetic Phenomenon. | Ashapkin VV et al. | β | 2017 | β |
| An update on stem cell biology and engineering for brain development. | Parr CJC et al. | β | 2017 | β |
| Back and forth in time: Directing age in iPSC-derived lineages. | Cornacchia D et al. | β | 2017 | β |
| Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. | LΓ³pez-LeΓ³n M et al. | β | 2017 | β |
| Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate. | Wahlestedt M et al. | β | 2017 | β |
| Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons. | Tang Y et al. | β | 2017 | β |
| Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases. | Hung SSC et al. | β | 2017 | β |
| Efficient method to create integration-free, virus-free, <i>Myc</i> and <i>Lin28</i>-free human induced pluripotent stem cells from adherent cells. | Kamath A et al. | β | 2017 | β |
| From Stem Cell Research to Three-Dimensional Organoids and Their Applications in Cancer Research: Meeting Report on the 9th International Meeting of the Stem Cell Network North Rhine Westphalia. | Langer S et al. | β | 2017 | β |
| hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges. | Lukovic D et al. | β | 2017 | β |
| Human induced pluripotent stem cells as a research tool in Alzheimer's disease. | Robbins JP et al. | β | 2017 | β |
| Human induced pluripotent stem cells for modelling neurodevelopmental disorders. | Ardhanareeswaran K et al. | β | 2017 | β |
| Induced pluripotent stem cell models of lysosomal storage disorders. | Borger DK et al. | β | 2017 | β |
| Linking Telomere Regulation to Stem Cell Pluripotency. | Liu L | β | 2017 | β |
| Long Live Partial Reprogramming. | MariΓ³n RM et al. | β | 2017 | β |
| Overcoming barriers to reprogramming and differentiation in nonhuman primate induced pluripotent stem cells. | Hemmi JJ et al. | β | 2017 | β |
| Preventing aging with stem cell rejuvenation: Feasible or infeasible? | Honoki K | β | 2017 | β |
| Rejuvenation by Partial Reprogramming of the Epigenome. | Mendelsohn AR et al. | β | 2017 | β |
| REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways. | Drouin-Ouellet J et al. | β | 2017 | β |
| Sirt6 Promotes DNA End Joining in iPSCs Derived from Old Mice. | Chen W et al. | β | 2017 | β |
| The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine. | Iop L et al. | β | 2017 | β |
| The Potential of iPSCs for the Treatment of Premature Aging Disorders. | Compagnucci C et al. | β | 2017 | β |
| Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases. | Singh S et al. | β | 2016 | β |
| Aging of Stem and Progenitor Cells: Mechanisms, Impact on Therapeutic Potential, and Rejuvenation. | Nurkovic J et al. | β | 2016 | β |
| ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks. | Ho R et al. | β | 2016 | β |
| Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics. | Sala Frigerio C et al. | β | 2016 | β |
| Anti-Aging Strategies Based on Cellular Reprogramming. | Ocampo A et al. | β | 2016 | β |
| Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells. | Kondo H et al. | β | 2016 | β |
| Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets. | Porrello A et al. | β | 2016 | β |
| Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients. | Liu ML et al. | β | 2016 | β |
| Direct neuronal reprogramming: learning from and for development. | Masserdotti G et al. | β | 2016 | β |
| Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. | Mertens J et al. | β | 2016 | β |
| Human induced pluripotent stem cells: A disruptive innovation. | De Vos J et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells inΒ Huntington's Disease Research: ProgressΒ and Opportunity. | Tousley A et al. | β | 2016 | β |
| [In vitro generation of blood red cells from stem cells: a sketch of the future]. | Mazurier C et al. | β | 2016 | β |
| InΒ Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. | Ocampo A et al. | β | 2016 | β |
| IPSCs, a Promising Tool to Restore Muscle Atrophy. | Pareja-Galeano H et al. | β | 2016 | β |
| iPSCs: On the Road to Reprogramming Aging. | Soria-Valles C et al. | β | 2016 | β |
| Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts. | Huh CJ et al. | β | 2016 | β |
| Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. | Sackett SD et al. | β | 2016 | β |
| Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets. | Grubman A et al. | β | 2016 | β |
| Mutations in mitochondrial DNA regulate mitochondrial diseases and metastasis but do not regulate aging. | Hayashi JI et al. | β | 2016 | β |
| Phenotypic and functional changes in dermal primary fibroblasts isolated from intrinsically aged human skin. | Brun C et al. | β | 2016 | β |
| Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44(+)/CD24(-/low) Stem Cell Phenotype. | Gao X et al. | β | 2016 | β |
| Restoration of Mitochondrial NAD<sup>+</sup> Levels Delays Stem Cell Senescence and Facilitates Reprogramming of Aged Somatic Cells. | Son MJ et al. | β | 2016 | β |
| Stem cells for all ages, yet hostage to aging. | Finch CE et al. | β | 2016 | β |
| The Aging Epigenome. | Booth LN et al. | β | 2016 | β |
| The reverse control of irreversible biological processes. | Cho KH et al. | β | 2016 | β |
| The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance. | Teichroeb JH et al. | β | 2016 | β |
| Alzheimer's Disease: Mechanism and Approach to Cell Therapy. | Amemori T et al. | β | 2015 | β |
| A vlincRNA participates in senescence maintenance by relieving H2AZ-mediated repression at the INK4 locus. | Lazorthes S et al. | β | 2015 | β |
| Cell-based therapies of liver diseases: age-related challenges. | Yarygin KN et al. | β | 2015 | β |
| Cell Therapy Strategies to Combat Immunosenescence. | Stahl EC et al. | β | 2015 | β |
| Collagen complexes increase the efficiency of iPS cells generated using fibroblasts from adult mice. | Chang BS et al. | β | 2015 | β |
| Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells. | Trokovic R et al. | β | 2015 | β |
| Comparison of the Efficiency of Viral Transduction and Episomal Transfection in Human Fibroblast Reprogramming. | Vdovin AS et al. | β | 2015 | β |
| De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins. | Squillaro T et al. | β | 2015 | β |
| Direct Conversion Provides Old Neurons from Aged Donor's Skin. | Koch P | β | 2015 | β |
| Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. | Mertens J et al. | β | 2015 | β |
| Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery. | Cary WA et al. | β | 2015 | β |
| Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure. | Chiang CH et al. | β | 2015 | β |
| iPSCs as a major opportunity to understand and cure age-related diseases. | Lemey C et al. | β | 2015 | β |
| NF-ΞΊB activation impairs somatic cell reprogramming in ageing. | Soria-Valles C et al. | β | 2015 | β |
| Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. | Studer L et al. | β | 2015 | β |
| Reprint of "iPSCs, aging and age-related diseases". | Isobe K et al. | β | 2015 | β |
| Results from a horizon scan on risks associated with transplantation of human organs, tissues and cells: from donor to patient. | Herberts CA et al. | β | 2015 | β |
| Stem cell aging in adult progeria. | Cheung HH et al. | β | 2015 | β |
| Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model. | Chien Y et al. | β | 2015 | β |
| When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease. | Vera E et al. | β | 2015 | β |
| Aged iPSCs display an uncommon mitochondrial appearance and fail to undergo in vitro neurogenesis. | Masotti A et al. | β | 2014 | β |
| Aging of blood can be tracked by DNA methylation changes at just three CpG sites. | Weidner CI et al. | β | 2014 | β |
| Anti-senescence efficacy of radio-electric asymmetric conveyer technology. | Maioli M et al. | β | 2014 | β |
| Cellular reprogramming for understanding and treating human disease. | Kanherkar RR et al. | β | 2014 | β |
| Cellular senescence and its effector programs. | Salama R et al. | β | 2014 | β |
| Discovery of consensus gene signature and intermodular connectivity defining self-renewal of human embryonic stem cells. | Kim JJ et al. | β | 2014 | β |
| Drp1 is dispensable for mitochondria biogenesis in induction to pluripotency but required for differentiation of embryonic stem cells. | Wang L et al. | β | 2014 | β |
| Epigenome rejuvenation: HP1Ξ² mobility as a measure of pluripotent and senescent chromatin ground states. | Manukyan M et al. | β | 2014 | β |
| Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. | Victor MB et al. | β | 2014 | β |
| Imperfect asymmetry: The mechanism governing asymmetric partitioning of damaged cellular components during mitosis. | Pattabiraman S et al. | β | 2014 | β |
| Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead. | Freude K et al. | β | 2014 | β |
| Induced pluripotent stem cells in dermatology: potentials, advances, and limitations. | Bilousova G et al. | β | 2014 | β |
| iPSCs, aging and age-related diseases. | Isobe K et al. | β | 2014 | β |
| Modulators of cellular senescence: mechanisms, promises, and challenges from in vitro studies with dietary bioactive compounds. | Malavolta M et al. | β | 2014 | β |
| Off-target response of a Wip1 chemical inhibitor in skin keratinocytes. | Lee JS et al. | β | 2014 | β |
| Reversal of hepatocyte senescence after continuous in vivo cell proliferation. | Wang MJ et al. | β | 2014 | β |
| Stem cell senescence. Effects of REAC technology on telomerase-independent and telomerase-dependent pathways. | Rinaldi S et al. | β | 2014 | β |
| Telomerase protects werner syndrome lineage-specific stem cells from premature aging. | Cheung HH et al. | β | 2014 | β |
| The aging signature: a hallmark of induced pluripotent stem cells? | Rohani L et al. | β | 2014 | β |
| The molecular balancing act of p16(INK4a) in cancer and aging. | LaPak KM et al. | β | 2014 | β |
| The role of senescent cells in ageing. | van Deursen JM | β | 2014 | β |
| The scientific quest for lasting youth: prospects for curing aging. | de MagalhΓ£es JP | β | 2014 | β |
| A hierarchy in reprogramming capacity in different tissue microenvironments: what we know and what we need to know. | Liebau S et al. | β | 2013 | β |
| Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. | Svendsen CN | β | 2013 | β |
| Cellular reprogramming of human peripheral blood cells. | Zhang XB | β | 2013 | β |
| Concealing cellular defects in pluripotent stem cells. | Zhang W et al. | β | 2013 | β |
| Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective. | Bai Q et al. | β | 2013 | β |
| Human iPSC-based modeling of late-onset disease via progerin-induced aging. | Miller JD et al. | β | 2013 | β |
| Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells. | Phanthong P et al. | β | 2013 | β |
| MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. | Venables JP et al. | β | 2013 | β |
| Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice. | Himeno T et al. | β | 2013 | β |
| Mitochondrial regulation in pluripotent stem cells. | Xu X et al. | β | 2013 | β |
| mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient. | Heng BC et al. | β | 2013 | β |
| Nonviral cell labeling and differentiation agent for induced pluripotent stem cells based on mesoporous silica nanoparticles. | Chen W et al. | β | 2013 | β |
| p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. | Mondal AM et al. | β | 2013 | β |
| Pluripotent stem cells escape from senescence-associated DNA methylation changes. | Koch CM et al. | β | 2013 | β |
| Probing the depths of cellular senescence. | Baker DJ et al. | β | 2013 | β |
| Rapamycin induces pluripotent genes associated with avoidance of replicative senescence. | Pospelova TV et al. | β | 2013 | β |
| Rejuvenation of senescent cells-the road to postponing human aging and age-related disease? | Sikora E | β | 2013 | β |
| Reprogramming of fibroblasts from older women with pelvic floor disorders alters cellular behavior associated with donor age. | Wen Y et al. | β | 2013 | β |
| Studies that shed new light on aging. | Katcher HL | β | 2013 | β |
| To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture. | Willmann CA et al. | β | 2013 | β |
| Understanding telomere diseases through analysis of patient-derived iPS cells. | Batista LF et al. | β | 2013 | β |
| Aging and reprogramming: a two-way street. | Mahmoudi S et al. | β | 2012 | β |
| [Cellular senescence and the myth of Janus]. | Brondello JM et al. | β | 2012 | β |
| Epigenetic rejuvenation. | Manukyan M et al. | β | 2012 | β |
| Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. | Yagi T et al. | β | 2012 | β |
| Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. | Bajpai VK et al. | β | 2012 | β |
| Implications of long-term culture for mesenchymal stem cells: genetic defects or epigenetic regulation? | Wagner W | β | 2012 | β |
| iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins. | Shamis Y et al. | β | 2012 | β |
| iPSC technology to study human aging and aging-related disorders. | Liu GH et al. | β | 2012 | β |
| Making Sense of Extreme Longevity: Explorations Into the Spiritual Lives of Centenarians. | Manning LK et al. | β | 2012 | β |
| New insights into cell cycle regulation and DNA damage response in embryonic stem cells. | Suvorova II et al. | β | 2012 | β |
| Reprogramming aging and progeria. | Freije JM et al. | β | 2012 | β |
| Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective. | Tacutu R et al. | β | 2011 | β |